Joseph Pinto

13PUBLICATIONS
23CO-AUTHORS
Molecular targetsPredictive and prognostic markersVeterinary virologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Oct 30, 2024
Antibody-Drug Conjugates in Breast Cancer: Toward a Molecular Perspective Into Clinical Practice.

Roberto Paz-Manrique, Joseph A Pinto, Henry L Gomez Moreno

|Sep 09, 2022
Prognostic Capability of TNBC 3-Gene Score among Triple-Negative Breast Cancer Subtypes.

Jhajaira M Araujo, Gabriel De la Cruz-Ku, Melanie Cornejo

|May 21, 2021
Near-Complete Genome Sequences of 12 Peruvian Strains of Infectious Hypodermal and Hematopoietic Necrosis Virus Infecting the Shrimp Penaeus vannamei.

Luis A Salcedo-Mejía, Yerson Durán-Ramirez, Rodolfo Z Velazco-Peña

|Mar 25, 2021
Biological bases of cancer immunotherapy.

Maryanne M Gonzales Carazas, Joseph A Pinto, Fanny L Casado

|Feb 01, 2021
PUM1 and RNase P genes as potential cell-free DNA markers in breast cancer.

Alexis Murillo Carrasco, Oscar Acosta, Jaime Ponce

|Jul 27, 2020
Lymph node ratio as best prognostic factor in triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy.

Gabriel A De la Cruz-Ku, Diego Chambergo-Michilot, Bryan Valcarcel

Pageof 3

Frequent Collaborators

5 joint publications

Jhajaira M Araujo

3 joint publications

Luis E Raez

2 joint publications

Christian Rolfo

2 joint publications

Gabriel De la Cruz-Ku